Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDECABTAGENE VICLEUCEL vs IMATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IDECABTAGENE VICLEUCEL vs IMATINIB: Safety Overview

Metric IDECABTAGENE VICLEUCEL IMATINIB
Total FAERS Reports 1,037 43,161
Deaths Reported 137 13,761
Death Rate 13.2% 31.9%
Hospitalizations 356 7,264
Average Patient Age 65.3 yrs 55.7 yrs
% Female Patients 41.9% 47.2%
FDA Approval Date N/A Apr 14, 2025
Manufacturer Celgene Corporation Dr.Reddy's Laboratories Inc
Route INTRAVENOUS ORAL
Marketing Status N/A Discontinued